Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$11.18 - $24.02 $4.81 Million - $10.3 Million
-430,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$20.95 - $26.88 $3.06 Million - $3.92 Million
-145,940 Reduced 25.34%
430,000 $10.2 Million
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $1.13 Million - $1.77 Million
65,533 Added 12.84%
575,940 $14.7 Million
Q2 2021

Aug 16, 2021

BUY
$17.76 - $24.83 $8.53 Million - $11.9 Million
480,407 Added 1601.36%
510,407 $10.7 Million
Q1 2021

May 17, 2021

BUY
$13.48 - $23.77 $404,400 - $713,100
30,000 New
30,000 $705,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.52B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.